BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32505868)

  • 1. Effect of prophylactic granulocyte-colony stimulating factor (G-CSF) on acute hematological toxicity in medulloblastoma patients during craniospinal irradiation (CSI).
    Madan R; Kumar N; Gupta A; Gupta K; Salunke P; Khosla D; Yadav BS; Kapoor R
    Clin Neurol Neurosurg; 2020 Sep; 196():105975. PubMed ID: 32505868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of acute hematological toxicity on treatment interruptions during cranio-spinal irradiation in medulloblastoma: a tertiary care institute experience.
    Kumar N; Miriyala R; Thakur P; Madan R; Salunke P; Yadav B; Gupta A
    J Neurooncol; 2017 Sep; 134(2):309-315. PubMed ID: 28577033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Multi-institutional Comparative Analysis of Proton and Photon Therapy-Induced Hematologic Toxicity in Patients With Medulloblastoma.
    Liu KX; Ioakeim-Ioannidou M; Susko MS; Rao AD; Yeap BY; Snijders AM; Ladra MM; Vogel J; Zaslowe-Dude C; Marcus KJ; Yock TI; Grassberger C; Braunstein SE; Haas-Kogan DA; Terezakis SA; MacDonald SM
    Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):726-735. PubMed ID: 33243479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton therapy for adult medulloblastoma: Acute toxicity and disease control outcomes.
    Liu IC; Holtzman AL; Rotondo RL; Indelicato DJ; Gururangan S; Cavaliere R; Carter B; Morris CG; Tavanaiepour D; Rutenberg MS
    J Neurooncol; 2021 Jul; 153(3):467-476. PubMed ID: 34105033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute toxicity profile of craniospinal irradiation with intensity-modulated radiation therapy in children with medulloblastoma: A prospective analysis.
    Cox MC; Kusters JM; Gidding CE; Schieving JH; van Lindert EJ; Kaanders JH; Janssens GO
    Radiat Oncol; 2015 Nov; 10():241. PubMed ID: 26597178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical combinations of radiation dose and volume predict intelligence quotient and academic achievement scores after craniospinal irradiation in children with medulloblastoma.
    Merchant TE; Schreiber JE; Wu S; Lukose R; Xiong X; Gajjar A
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):554-61. PubMed ID: 25160611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
    Massimino M; Gandola L; Spreafico F; Biassoni V; Luksch R; Collini P; Solero CN; Simonetti F; Pignoli E; Cefalo G; Poggi G; Modena P; Mariani L; Potepan P; Podda M; Casanova M; Pecori E; Acerno S; Ferrari A; Terenziani M; Meazza C; Polastri D; Ravagnani F; Fossati-Bellani F
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1358-63. PubMed ID: 19019566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late toxicity following craniospinal radiation for early-stage medulloblastoma.
    Christopherson KM; Rotondo RL; Bradley JA; Pincus DW; Wynn TT; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
    Acta Oncol; 2014 Apr; 53(4):471-80. PubMed ID: 24564687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The change in patterns of relapse in medulloblastoma.
    Tarbell NJ; Loeffler JS; Silver B; Lynch E; Lavally BL; Kupsky WJ; Scott RM; Sallan SE
    Cancer; 1991 Oct; 68(7):1600-4. PubMed ID: 1893359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian function in survivors of childhood medulloblastoma: Impact of reduced dose craniospinal irradiation and high-dose chemotherapy with autologous stem cell rescue.
    Balachandar S; Dunkel IJ; Khakoo Y; Wolden S; Allen J; Sklar CA
    Pediatr Blood Cancer; 2015 Feb; 62(2):317-321. PubMed ID: 25346052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome and toxicity using helical tomotherapy for craniospinal irradiation in pediatric medulloblastoma.
    Lopez Guerra JL; Marrone I; Jaen J; Bruna M; Sole C; Sanchez-Reyes A; Rivin E; Ortiz MJ; Calvo F; Matute R
    Clin Transl Oncol; 2014 Jan; 16(1):96-101. PubMed ID: 23632814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.
    Merchant TE; Kun LE; Krasin MJ; Wallace D; Chintagumpala MM; Woo SY; Ashley DM; Sexton M; Kellie SJ; Ahern V; Gajjar A
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):782-7. PubMed ID: 17892918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scoliosis in Children Treated With Photon Craniospinal Irradiation for Medulloblastoma.
    Paulino AC; Suzawa HS; Dreyer ZE; Hanania AN; Chintagumpala M; Okcu MF
    Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):712-717. PubMed ID: 33516438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of combined preradiation chemotherapy and age-tailored radiotherapy doses for childhood medulloblastoma.
    Massimino M; Cefalo G; Riva D; Biassoni V; Spreafico F; Pecori E; Poggi G; Collini P; Pollo B; Valentini L; Potepan P; Seregni E; Casanova M; Ferrari A; Luksch R; Polastri D; Terenziani M; Pallotti F; Clerici CA; Schiavello E; Simonetti F; Meazza C; Catania S; Podda M; Gandola L
    J Neurooncol; 2012 May; 108(1):163-71. PubMed ID: 22350379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of failure in children with medulloblastoma: effects of preirradiation chemotherapy.
    Hartsell WF; Gajjar A; Heideman RL; Langston JA; Sanford RA; Walter A; Jones D; Chen G; Kun LE
    Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):15-24. PubMed ID: 9300735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study on the risks of radiogenic second cancers and cardiac mortality in a set of pediatric medulloblastoma patients treated with photon or proton craniospinal irradiation.
    Zhang R; Howell RM; Taddei PJ; Giebeler A; Mahajan A; Newhauser WD
    Radiother Oncol; 2014 Oct; 113(1):84-8. PubMed ID: 25128084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant weekly vincristine and radiation followed by adjuvant vincristine and carboplatin in the treatment of high risk medulloblastoma: Ain Shams University Hospital and Sohag Cancer Center study.
    Salama MM; Ghorab EM; Al-Abyad AG; Al-Bahy KM
    J Egypt Natl Canc Inst; 2006 Jun; 18(2):167-74. PubMed ID: 17496943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton beam craniospinal irradiation reduces acute toxicity for adults with medulloblastoma.
    Brown AP; Barney CL; Grosshans DR; McAleer MF; de Groot JF; Puduvalli VK; Tucker SL; Crawford CN; Khan M; Khatua S; Gilbert MR; Brown PD; Mahajan A
    Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):277-84. PubMed ID: 23433794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study of preirradiation chemotherapy and 1800 cGy craniospinal irradiation in young children with medulloblastoma.
    Jakacki RI; Feldman H; Jamison C; Boaz JC; Luerssen TG; Timmerman R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):531-6. PubMed ID: 15380589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of dosimetric and toxicity modeling of proton versus photon craniospinal irradiation for pediatrics medulloblastoma.
    Ho ESQ; Barrett SA; Mullaney LM
    Acta Oncol; 2017 Aug; 56(8):1031-1042. PubMed ID: 28509599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.